VINDESINE: 1,946 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,946
Total FAERS Reports
283 (14.5%)
Deaths Reported
759
Hospitalizations
1,946
As Primary/Secondary Suspect
211
Life-Threatening
34
Disabilities
First Report: 19960816 · Latest Report: 20250910
What Are the Most Common VINDESINE Side Effects?
#1 Most Reported
Myelosuppression
429 reports (22.0%)
#2 Most Reported
Off label use
148 reports (7.6%)
#3 Most Reported
Bone marrow failure
141 reports (7.2%)
All VINDESINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 429 | 22.1% | 5 | 263 |
| Off label use | 148 | 7.6% | 21 | 60 |
| Bone marrow failure | 141 | 7.3% | 20 | 79 |
| Pyrexia | 138 | 7.1% | 6 | 94 |
| Anaemia | 137 | 7.0% | 23 | 41 |
| Leukopenia | 127 | 6.5% | 14 | 31 |
| White blood cell count decreased | 124 | 6.4% | 3 | 54 |
| Febrile neutropenia | 115 | 5.9% | 14 | 65 |
| Pneumonia | 110 | 5.7% | 30 | 28 |
| Thrombocytopenia | 93 | 4.8% | 22 | 23 |
| Neutropenia | 89 | 4.6% | 16 | 28 |
| Neutrophil count decreased | 87 | 4.5% | 5 | 28 |
| Drug ineffective | 85 | 4.4% | 23 | 29 |
| Infection | 69 | 3.6% | 30 | 25 |
| Disease progression | 67 | 3.4% | 22 | 16 |
| Stomatitis | 60 | 3.1% | 5 | 38 |
| Product use in unapproved indication | 56 | 2.9% | 10 | 15 |
| Hypokalaemia | 53 | 2.7% | 4 | 6 |
| Sepsis | 53 | 2.7% | 28 | 12 |
| Agranulocytosis | 51 | 2.6% | 6 | 25 |
Who Reports VINDESINE Side Effects? Age & Gender Data
Gender: 41.4% female, 58.6% male. Average age: 40.8 years. Most reports from: CN. View detailed demographics →
Is VINDESINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 1 | 0 | 0 |
| 2003 | 2 | 0 | 0 |
| 2006 | 4 | 0 | 3 |
| 2007 | 17 | 0 | 16 |
| 2008 | 5 | 0 | 0 |
| 2009 | 1 | 1 | 1 |
| 2010 | 2 | 1 | 0 |
| 2011 | 6 | 0 | 2 |
| 2012 | 14 | 5 | 3 |
| 2013 | 18 | 5 | 10 |
| 2014 | 26 | 3 | 23 |
| 2015 | 70 | 6 | 36 |
| 2016 | 61 | 5 | 29 |
| 2017 | 50 | 3 | 21 |
| 2018 | 60 | 4 | 28 |
| 2019 | 99 | 7 | 58 |
| 2020 | 79 | 3 | 42 |
| 2021 | 110 | 4 | 62 |
| 2022 | 128 | 2 | 74 |
| 2023 | 179 | 0 | 97 |
| 2024 | 97 | 0 | 52 |
| 2025 | 44 | 0 | 38 |
What Is VINDESINE Used For?
| Indication | Reports |
|---|---|
| Diffuse large b-cell lymphoma | 279 |
| Acute lymphocytic leukaemia | 272 |
| Non-hodgkin's lymphoma | 131 |
| Chemotherapy | 118 |
| Lymphoma | 104 |
| B-cell lymphoma | 93 |
| Hodgkin's disease | 74 |
| Neuroblastoma | 65 |
| Adult t-cell lymphoma/leukaemia | 61 |
| Burkitt's lymphoma | 58 |
VINDESINE vs Alternatives: Which Is Safer?
VINDESINE vs VINORELBINE
VINDESINE vs VINORELBINE\VINORELBINE
VINDESINE vs VIREAD
VINDESINE vs VISIPAQUE
VINDESINE vs VISMODEGIB
VINDESINE vs VITAMIN A
VINDESINE vs VITAMIN B
VINDESINE vs VITAMIN D NOS
VINDESINE vs VITAMINS
VINDESINE vs VOCLOSPORIN
Official FDA Label for VINDESINE
Official prescribing information from the FDA-approved drug label.